147 related articles for article (PubMed ID: 36960636)
21. Differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma using CT features: a central scar-matched retrospective study.
Li X; Nie P; Zhang J; Hou F; Ma Q; Cui J
Acta Radiol; 2022 Feb; 63(2):253-260. PubMed ID: 33497276
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of MDCT to Differentiate Between Renal Cell Carcinoma and Oncocytoma: Development of a Predictive Model.
Paño B; Macías N; Salvador R; Torres F; Buñesch L; Sebastià C; Nicolau C
AJR Am J Roentgenol; 2016 Apr; 206(4):764-74. PubMed ID: 26914689
[TBL] [Abstract][Full Text] [Related]
23. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
[TBL] [Abstract][Full Text] [Related]
24. The value of CT features and demographic data in the differential diagnosis of type 2 papillary renal cell carcinoma from fat-poor angiomyolipoma and oncocytoma.
Zhou C; Ban X; Luo L; Shi C
Abdom Radiol (NY); 2022 Nov; 47(11):3838-3846. PubMed ID: 36085376
[TBL] [Abstract][Full Text] [Related]
25. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.
Bird VG; Kanagarajah P; Morillo G; Caruso DJ; Ayyathurai R; Leveillee R; Jorda M
World J Urol; 2011 Dec; 29(6):787-92. PubMed ID: 20717829
[TBL] [Abstract][Full Text] [Related]
27. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
Cornelis F; Lasserre AS; Tourdias T; Deminière C; Ferrière JM; Le Bras Y; Grenier N
AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula.
Kopp RP; Aganovic L; Palazzi KL; Cassidy FH; Sakamoto K; Derweesh IH
Can J Urol; 2013 Jun; 20(3):6790-7. PubMed ID: 23783049
[TBL] [Abstract][Full Text] [Related]
29. Comparison of segmental enhancement inversion on biphasic MDCT between small renal oncocytomas and chromophobe renal cell carcinomas.
Woo S; Cho JY; Kim SH; Kim SY
AJR Am J Roentgenol; 2013 Sep; 201(3):598-604. PubMed ID: 23971452
[TBL] [Abstract][Full Text] [Related]
30. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms.
Choudhary S; Rajesh A; Mayer NJ; Mulcahy KA; Haroon A
Clin Radiol; 2009 May; 64(5):517-22. PubMed ID: 19348848
[TBL] [Abstract][Full Text] [Related]
31. Association of qualitative and quantitative imaging features on multiphasic multidetector CT with tumor grade in clear cell renal cell carcinoma.
Coy H; Young JR; Douek ML; Pantuck A; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2019 Jan; 44(1):180-189. PubMed ID: 29987358
[TBL] [Abstract][Full Text] [Related]
32. Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI.
Akın IB; Altay C; Güler E; Çamlıdağ İ; Harman M; Danacı M; Tuna B; Yörükoğlu K; Seçil M
Diagn Interv Radiol; 2019 Jan; 25(1):5-13. PubMed ID: 30644365
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of renal angiomyolipoma without visible fat from small clear cell renal cell carcinoma by using specific region of interest on contrast-enhanced CT: a new combination of quantitative tools.
Wang X; Song G; Jiang H
Cancer Imaging; 2021 Jul; 21(1):47. PubMed ID: 34225784
[TBL] [Abstract][Full Text] [Related]
35. Utility of the Aortic-Lesion-Attenuation-Difference (ALAD) and Peak Early-Phase Enhancement Ratio (PEER) to differentiate benign from malignant renal masses.
Kahn AE; Lomax SJ; Bajalia EM; Ball CT; Thiel DD
Can J Urol; 2020 Aug; 27(4):10278-10284. PubMed ID: 32861252
[TBL] [Abstract][Full Text] [Related]
36. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
[TBL] [Abstract][Full Text] [Related]
37. [Role of multiphasic multidetector CT imaging in differential diagnosis of small renal cell carcinoma].
Zhang Y; Gao W; Zhao B; Zhang X
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):850-4. PubMed ID: 26887517
[TBL] [Abstract][Full Text] [Related]
38. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
Halefoglu AM; Ozagari AA
Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
[TBL] [Abstract][Full Text] [Related]
39. A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study.
Li X; Ma Q; Nie P; Zheng Y; Dong C; Xu W
Br J Radiol; 2022 Jan; 95(1129):20210534. PubMed ID: 34735296
[TBL] [Abstract][Full Text] [Related]
40. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
